Obeidat Omar, Ismail Mohamed F, Abughazaleh Saeed, Al-Ani Hashim, Tarawneh Mohammad, Alhuneafat Laith, Obeidat Ali, Obeidat Abedallah, Alqudah Qusai, Daise Moh'd Alamin, Alzghoul Hamza, Al-Hammouri Mohammad, Althunibat Ward, Tong Ann, Alimohamed Mazahir
Graduate Medical Education Program, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Internal Medicine Residency Program, HCA Florida North Florida Hospital, Gainesville, FL 32605, USA.
Med Int (Lond). 2024 Nov 5;5(1):1. doi: 10.3892/mi.2024.200. eCollection 2025 Jan-Feb.
The present study reviews the role of catheter ablation (CA) in the management of atrial fibrillation (AF), a widespread arrhythmia associated with increased morbidity and mortality. The present review explores current indications and recent evidence supporting CA, assessing patient outcomes and identifying common complications associated with the procedure. Emphasis is placed on optimizing risk factors prior to ablation, including weight control and hypertension management, as these measures can significantly enhance post-procedural outcomes. The present review also discusses the use of antiarrhythmic and anticoagulant therapies following CA to minimize recurrence and reduce stroke risk. Additionally, the cost-effectiveness of CA is discussed, comparing its long-term economic impact with that of medical therapy alone. The present comprehensive review provides insight into best practices for AF management, supporting CA as a promising approach when integrated with targeted lifestyle modifications and pharmacological support for improved, patient-centered outcomes.
本研究回顾了导管消融术（CA）在心房颤动（AF）管理中的作用，心房颤动是一种普遍存在的心律失常，与发病率和死亡率增加相关。本综述探讨了支持CA的当前适应症和最新证据，评估了患者预后，并确定了与该手术相关的常见并发症。重点是在消融术前优化危险因素，包括体重控制和高血压管理，因为这些措施可以显著提高术后预后。本综述还讨论了CA术后使用抗心律失常和抗凝治疗以尽量减少复发和降低中风风险。此外，还讨论了CA的成本效益，将其长期经济影响与单纯药物治疗进行了比较。本全面综述深入探讨了AF管理的最佳实践，支持将CA作为一种有前景的方法，与有针对性的生活方式改变和药物支持相结合，以改善以患者为中心的预后。
